HomeZantacLatest Zantac News
Posted in Zantac on 13th May 2014

Predicting new drug sales is more art than science
Prior to the introduction of the “blockbuster” histamine H-2 antagonists, first Tagamet and then Zantac, for gastrointestinal (GI) reflux and ulcers, the GI market was seen as limited. Patients were treated with antacids, which had only modest efficacy …
Read more on ValueWalk

Related Post for FDA Safety Changes: Zantac, Zithromax, Noxafil

Zantac, Product Mgr: Heartburn?!…Don’t just attack it – Zantac it!TM
Zantac TV Commercial Fireman
The Best Return on Equity in Healthcare
Latest Zantac News
FDA Safety Changes: Zantac, Zithromax, Noxafil
tags: , ,